Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Anesthesiology. 2008 Sep;109(3):491–501. doi: 10.1097/ALN.0b013e318182a4a3

Fig. 2.

Fig. 2

Effect of posterior lumbar plexus perineural ropivacaine infusion on the time to reach three predefined discharge criteria (adequate analgesia, independence from intravenous opioids, and the ability to ambulate at least 30 m) after hip arthroplasty. Data presented are Kaplan-Meier estimates of the cumulative percentages of patients meeting all three discharge criteria at each time point and subsequent time points. Data are for patients randomly assigned to the ropivacaine group (perineural ropivacaine from surgery through postoperative day 4) or the placebo group (perineural ropivacaine from surgery through 06:00 postoperative day 1 followed by perineural normal saline through postoperative day 4).